Among patients without rheumatic disease, there was no evidence of an effect on mortality of cANCA and pANCA compared with no ANCA (respectively, HR, 0.75; 95% CI, 0.27–2.05 and HR, 1.23; 95% CI, 0.75–2.02). Here, PRTN3 is linked to rheumatic disorder.